Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Antimicrobial Stewardship in Pediatric Surgery (AbxPS)

16. März 2018 aktualisiert von: Dr Anna Shawyer, Alberta Children's Hospital

An Antimicrobial Stewardship Intervention Program in Pediatric Surgery

Acute appendicitis is a common surgical emergency in children. Non-perforated appendicitis patients do not require antibiotics after appendectomy. Although guidelines and recommendations exist to decrease post-operative antibiotic mis-use after appendectomy, surgeons continue to prescribe unwarranted antibiotics.

The aim of this study is to determine if an Antimicrobial Stewardship Program in Pediatric Surgery will decrease the use of un-warranted antibiotics.

Studienübersicht

Status

Zurückgezogen

Bedingungen

Detaillierte Beschreibung

Many surgeons continue to treat non-perforated or "borderline perforated" appendicitis with postoperative antibiotics despite an evidence-based definition of perforation (in the pediatric surgical literature) and many guidelines and recommendations that specify that no postoperative antibiotics are required. Children with perforated appendicitis are also often treated with longer-than-necessary courses of antibiotics. Although surgeons may feel that they only prescribe additional doses on occasion, evidence suggests that this behavior occurs in over 50% of children with non-perforated appendicitis.

These additional doses contribute to a longer length of stay, excess costs to the health care system, and disrupt patient flow. Additionally, the patients are exposed to more antibiotics and their potential for adverse effects (such as incorrect dose, incorrect medication, allergic reaction, antimicrobial resistance or c difficile infection).

Antimicrobial stewardship programs have been successful in pediatrics and adult general surgery in curbing unwarranted antibiotic use, but have never been evaluated in pediatric general surgery.

Studientyp

Beobachtungs

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

Nicht älter als 18 Jahre (Kind, Erwachsene)

Akzeptiert gesunde Freiwillige

Ja

Studienberechtigte Geschlechter

Alle

Probenahmeverfahren

Wahrscheinlichkeitsstichprobe

Studienpopulation

The study population is the pediatric surgeons at our institution who will have their antibiotic prescribing audited.

Beschreibung

Inclusion Criteria:

  • Participant (surgeon) is a pediatric surgeon at McMaster Children's Hospital and takes care of patients under the age of 18 who undergo appendectomy.
  • Participant (surgeon) is able to read, write and understand English.
  • Participant (surgeon) is able to provide informed consent.

Exclusion Criteria:

  • Participant (surgeon) only has patients who undergo drain insertion, PICC line insertion or a secondary operation during the same admission
  • Participant (surgeon) only has patients who do not undergo operation (i.e. "conservative management with interval appendectomy)
  • Participant (surgeon) does not provide informed consent
  • Participant (surgeon) does not understand written and spoken English diagnosis other than appendicitis at time of operation

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

Kohorten und Interventionen

Gruppe / Kohorte
Intervention / Behandlung
NO Antimicrobial Stewardship Program
Prospective cohort of children who undergo appendectomy for acute appendicitis (perforated and non-perforated) BEFORE the implementation of the Antimicrobial Stewardship Program.
WITH Antimicrobial Stewardship Program
Prospective cohort of children who undergo appendectomy for acute appendicitis (perforated and non-perforated) WITH the implementation of the Antimicrobial Stewardship Program.
Twice weekly meeting with Infectious Disease and Pediatric Surgery team members to audit antibiotics prescribed and suggest role for discontinuation.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Compliance with American Pediatric Surgical Association recommendations for postoperative antibiotics for appendicitis
Zeitfenster: From date of admission until first follow-up visit, typically within 4-6 weeks of discharge
Includes both intravenous and oral antibiotics prescribed, both during the time frame from admission until discharge, in addition to any prescription given for home, oral antibiotics. Measured as yes/no
From date of admission until first follow-up visit, typically within 4-6 weeks of discharge

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Postoperative intravenous antibiotics for non-perforated appendicitis
Zeitfenster: From date of admission until first follow-up visit, typically within 4-6 weeks of discharge
measured as number of days (ie number of doses divided by number of doses-per-day)
From date of admission until first follow-up visit, typically within 4-6 weeks of discharge
Postoperative oral antibiotics for non-perforated appendicitis
Zeitfenster: From date of admission until first follow-up visit, typically within 4-6 weeks of discharge
measured as number of days (ie number of doses divided by number of doses-per-day)
From date of admission until first follow-up visit, typically within 4-6 weeks of discharge

Andere Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Postoperative fever
Zeitfenster: Length of admission
Rectal temperature above 100.4ºF (38ºC), measured as yes/no and on what postoperative day Oral temperature above 100ºF (37.8ºC) Axillary (armpit) temperature above 99ºF (37.2ºC) Ear (tympanic membrane) temperature above 100.4ºF (38ºC) in rectal mode or 99.5ºF (37.5ºC) in oral mode Forehead (temporal artery) temperature above 100.4ºF (38ºC)
Length of admission
Readmission within 30 days
Zeitfenster: Within 30 days of discharge
Need for readmission within 30 days of discharge, measured as yes/no
Within 30 days of discharge
Peripherally inserted intravenous catheter (PICC)
Zeitfenster: From date of admission until first follow-up visit, typically within 4-6 weeks of discharge
Need for PICC insertion for long term antibiotics, intravenous fluids or parenteral nutrition, measured as yes/no
From date of admission until first follow-up visit, typically within 4-6 weeks of discharge
Drain insertion
Zeitfenster: From date of admission until first follow-up visit, typically within 4-6 weeks of discharge
Need for a drain insertion (by interventional radiology) for postoperative abscess, measured as yes/no
From date of admission until first follow-up visit, typically within 4-6 weeks of discharge
Re-operation
Zeitfenster: From date of admission until first follow-up visit, typically within 4-6 weeks of discharge
Need for re-operation on the same admission, measured as yes/no
From date of admission until first follow-up visit, typically within 4-6 weeks of discharge
Length of Stay
Zeitfenster: Length of admission
Measured in days (from date of admission until date of discharge)
Length of admission
Adverse reaction to antibiotic
Zeitfenster: From date of admission until first follow-up visit, typically within 4-6 weeks of discharge
Measured as yes/no in addition to description of reaction (eg hives, shortness of breath)
From date of admission until first follow-up visit, typically within 4-6 weeks of discharge
Wrong medication/Wrong dose
Zeitfenster: From date of admission until date of first follow-up visit, typically within 4-6 weeks of discharge
Measured as yes/no in addition to description of problem (wrong dose, wrong medication)
From date of admission until date of first follow-up visit, typically within 4-6 weeks of discharge
C difficile infection
Zeitfenster: From date of admission until first follow-up visit, typically within 4-6 weeks of discharge
Measured as yes/no based on stool assay
From date of admission until first follow-up visit, typically within 4-6 weeks of discharge

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Hauptermittler: Anna Shawyer, MS, MSc, Alberta Children's Hospital

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn

1. Januar 2015

Primärer Abschluss (Voraussichtlich)

1. Dezember 2015

Studienabschluss (Voraussichtlich)

1. Dezember 2015

Studienanmeldedaten

Zuerst eingereicht

8. Oktober 2014

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

21. Oktober 2014

Zuerst gepostet (Schätzen)

22. Oktober 2014

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

20. März 2018

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

16. März 2018

Zuletzt verifiziert

1. März 2018

Mehr Informationen

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren